Your browser doesn't support javascript.
loading
T follicular helper cells: linking cancer immunotherapy and immune-related adverse events.
Baumjohann, Dirk; Brossart, Peter.
Affiliation
  • Baumjohann D; Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Bonn, Germany dirk.baumjohann@uni-bonn.de.
  • Brossart P; Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Bonn, Germany.
J Immunother Cancer ; 9(6)2021 06.
Article in En | MEDLINE | ID: mdl-34112740
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug-Related Side Effects and Adverse Reactions / T Follicular Helper Cells / Immunotherapy Limits: Humans Language: En Journal: J Immunother Cancer Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug-Related Side Effects and Adverse Reactions / T Follicular Helper Cells / Immunotherapy Limits: Humans Language: En Journal: J Immunother Cancer Year: 2021 Document type: Article Affiliation country: